Translocation t(X;20)(q13;q13.3) as a secondary chromosome abnormality in a patient with 5q-: a case report

Autor: de Matos Jl Rodrigues, Sha Figueira, Correia Ca Figueiredo, RK Kishimoto, Ratis C Alonso, Pereira Velloso Ed Rodrigues

Publikováno v: Atlas of Genetics and Cytogenetics in Oncology and Haematology.

Case report of a translocation : Translocation t(X;20)(q13;q13.3) as a secondary chromosome abnormality in a patient with 5q-: a case report.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fc0a4b9c1dbaeafdc3511af181e02ca6
https://doi.org/10.4267/2042/51053

A new case of translocation t(14;14)(q11;q32) in B lineage ALL

Autor: Daniela Borri, Clp Mangueira, da Silva Lj Rodrigues, Melillo K Prandi, dos Santos Teixeira P Pereira, Ratis C Alonso, Pereira Velloso Ed Rodrigues

Publikováno v: Atlas of Genetics and Cytogenetics in Oncology and Haematology.

Case report of a translocation : A new case of translocation t(14;14)(q11;q32) in B lineage ALL.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d4e4d7fb8feb82dbdc723ce307e8cb89
https://doi.org/10.4267/2042/46023

Translocation t(5;17)(q13;q21) as the sole cytogenetic anomaly in acute myeloid leukemia after chemotherapy and allogeneic bone marrow transplantation for AML-M4: a case report

Autor: E Cabral, D Gonsalez, NS Bacal, Clp Mangueira, CA Ratis, Pereira Velloso Ed Rodrigues

Publikováno v: Atlas of Genetics and Cytogenetics in Oncology and Haematology.

Case report of a translocation : Translocation t(5;17)(q13;q21) as the sole cytogenetic anomaly in acute myeloid leukemia after chemotherapy and allogeneic bone marrow transplantation for AML-M4: a case report.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47a622b0dfc0af4282e0413214382397
https://doi.org/10.4267/2042/44550

Dicentric dic(7;9)(p11;p11): a new case in childhood ALL

Autor: Oliveira Fm de, Pereira Velloso Ed Rodrigues, C Kassab, DT Noguchi, Clp Mangueira, Sha Figueira, Benites Ec Armelin

Publikováno v: Atlas of Genetics and Cytogenetics in Oncology and Haematology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f09eece3d4e8f55070a4e33fcfa179f4
https://doi.org/10.4267/2042/44836

Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation.

Autor: Silva WF; Division of Hematology, Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Amano MT; Instituto Sírio-Libanês de Ensino e Pesquisa, Hospital Sírio-Libanês, São Paulo, Brazil., Perruso LL; Division of Hematology, Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil., Cordeiro MG; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil.; Hospital Israelita Albert Einstein, São Paulo, Brazil., Kishimoto RK; Hospital Israelita Albert Einstein, São Paulo, Brazil., de Medeiros Leal A; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil., Nardinelli L; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Bendit I; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Velloso ED; Division of Hematology, Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.; Hospital Israelita Albert Einstein, São Paulo, Brazil., Rego EM; Division of Hematology, Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Rocha V; Division of Hematology, Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.

Publikováno v: Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 396-403.